The NIAID/Radiation and Nuclear Countermeasures Program (RNCP) has been tasked with developing safe and effective medical countermeasures (MCMs) and biodosimetry tools for civilians, which can be used at least 24 hours post-exposure during a radiological or nuclear public health emergency. Although the pediatric population makes up ~25% of the total population; research and development in these areas has focused primarily on adults. Additional efforts are needed to develop the radiation pediatric animal models necessary to study MCMs and to generate samples for biodosimetry tool validation. The goal of this initiative is to promote pediatric-specific research to enable the advancement of pediatric MCMs and biodosimetry tools. This is currently an unmet need that impacts the safety and public health of the pediatric population. Administrative supplements can be used to meet increased costs associated with the development of pediatric models, pediatric sample collection, and analysis that are within the scope of the approved award. Applicants should propose research that, if successful, would contribute to a greater understanding of the health and well-being of the pediatric population after a radiation incident. First available due date: November 1, 2020. Visit NOT-AI-20-061 for application and submission information. |
Friday, July 17, 2020
Availability of Funds for Administrative Supplements for Pediatric Radiation/Nuclear Animal Models, MCM, Biodosimetry Development
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment